Skip to main content
. 2022 Mar 18;34(1):9–15. doi: 10.5830/CVJA-2022-013

Table 2. TTE and CMR data.

TTE and CMR data Number (%) or mean + SD
LVEDV TTE (ml/m²) 95.9 + 27.4
LVESV TTE (ml/m²) 41.1 + 21.1
LVEDD TTE (mm) 61.4 + 7.8
LVESD TTE (mm) 43.2 + 9.1
LVEF) TTE 54.1 + 10.5
RVo1 (ml) 53.3 + 21.6
EDVDA (cm/s) 18.1 + 6.4
PHT (ms) 460.6 + 153.1
Vena contracta (mm) 5.3 + 2.4
Inconclusive quantification by TTE 25 (50)
Number of quantification methods by TTE
One method 20 (40)
Two methods 14 (28)
Three methods 8 (16)
Four methods 8 (16)
Disagreement between TTE methods 5 (10)
LVEDV CMR (ml/m²) 133.3 + 38.1
LVESV CMR (ml/m²) 65.1 + 25.5
RF CMR (%) 35.5 + 14.1
RVolcME CMR (ml) 29.7 + 17.1
LVEF CMR (%) 51.8 + 8.6
Late gadolinium enhancement 5 (10)

TTE, transthoracic echocardiography; CMR, cardiovascular magnetic resonance imaging; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; RVol, regurgitant volume; EDVDA, end-diastolic velocity in the descending aorta; PHT, pressure half-time; RF, regurgitant fraction.